key: cord-0846893-t9tshi2c
authors: Cunha, Burke A.
title: Swine Influenza (H1N1) Pneumonia: Clinical Considerations
date: 2010-02-18
journal: Infect Dis Clin North Am
DOI: 10.1016/j.idc.2009.10.001
sha: 37bb13be9b61ad8d2ff2ed3142825ca4a8a56256
doc_id: 846893
cord_uid: t9tshi2c

Influenza is a viral zoonosis of birds and mammals that has probably existed since antiquity. Attack rates of influenza are relatively high but mortality is relatively low. Influenza mortality is highest in the very young, the very old, and the immunosuppressed. Influenza has the potential for rapid spread and may involve large populations. This article examines the swine influenza (H1N1) strain of recent origin, and compares the microbiology, epidemiology, clinical presentation, differential, clinical, and laboratory diagnosis, therapy, complications, and prognosis with previous recorded outbreaks of avian and human seasonal influenza pneumonias.

However, only 3 HA subtypes and 2 NA subtypes have been implicated in human influenza epidemics. The 3 HA subtypes in human outbreaks are H1, H2, and H3, and the 2 NA subtypes are N1 and N2. The surface HA proteins are HA glycoproteins in a rodshaped spike with a hydrophobic carboxy terminal based in the viral envelope. The hydrophobic end of the rod-shaped spike projects from the virus and is the binding site for sialic acid residues in host receptor cells. The HA surface glycoprotein is responsible for viral adherence to the host cell, whereas the HA glycoprotein is responsible for attachment of the virus and penetration of the influenza A virus into the host cell. The NA surface glycoprotein is mushroom-shaped and is also implanted in the lipid envelope at the amino acid end of the glycoprotein. NA glycoprotein cleaves terminal sialic acid residues, which are responsible for release of virus from infected host cells and spread of the influenza virus to other cells in the respiratory tract. Influenza viruses also have M2 proteins, which are important in uncoding the virus. M2 proteins, which are the matrix proteins, are present only in influenza A viruses and appear on the surface of infected host cells. M1 proteins are surface structural proteins important in viral budding. [22] [23] [24] Influenza A and B viruses bind to sialic acid receptors on the host cell surface and begin the infectious process. Human influenza viruses attach preferentially to the a2, 6 linkage to galactose containing oligosaccharides. In contrast, avian influenza viruses preferentially bind to a23 linkages. Influenza C viruses bind to 9-O-acetyl-N-acetylneuraminic acid receptors. Influenza A viruses are widely distributed in nature. Avian species are the primary reservoir for all 16 HA and 9 NA influenza A subtypes. Other natural hosts of influenza A viruses are humans, horses, and swine. Human influenza viruses replicate in respiratory epithelial cells, whereas avian influenza A virus is replicated in respiratory and gastrointestinal epithelial cells. [22] [23] [24] [25] Swine influenza is an influenza A virus that consists of distinctive genetic influenza A elements from swine, human, avian, and Eurasian swine strains of influenza (H1N1). The swine influenza (H1N1) pandemic was totally unpredicted. As with the ''herald waves'' of previous influenza A pandemics, large numbers of people were infected but relatively few died. The virulence of avian influenza (H5N1) remains worrisome. 21 To date, avian influenza (H5N1) has been highly lethal in relatively small numbers of patients. It is thought that avian influenza (H5N1) is relatively inefficient in bird-tohuman and human-to-human transmission, thus far limiting its human pandemic potential. With the swine influenza (H1N1) pandemic, although mortality rates are low, the potential for pandemic spread has been demonstrated during the spring/ summer initial ''herald wave''. Lethal, swine influenza (H1N1) affects primarily young healthy adults. 5, 6, [22] [23] [24] [25] EPIDEMIOLOGY Influenza viruses are spread by airborne aerosols/droplets from infected individuals while speaking, coughing, or sneezing. Fomites are also implicated in the transmission of influenza. Nonhuman influenza infections are spread from respiratory/gastrointestinal infections of the host animal. 2, 3, 26 Influenza viruses remain viable at cool temperatures under conditions of low humidity on nonporous surfaces.

Influenza viruses may be detected in the general population throughout the year, but peak in the winter months. In the northern hemisphere, peak human seasonal influenza season is in February whereas in the southern hemisphere, where winter months occur between May and August, flu usually peaks in June or July. Epidemics of influenza A are characterized by a sudden increase in acute respiratory illnesses. In epidemics, usually influenza A or influenza B predominates, although both influenza A and B Swine Influenza (H1N1) Pneumonia may occur together in epidemics. Avian influenza (H5N1) may be transmitted from direct contact with infected birds or humans. 2, 5, 22, 23 Influenza has a short incubation period of approximately 2 days (range, 1-5 days). During the initial phase of the illness, there are high concentrations of influenza virus in respiratory secretions responsible for its spread via airborne transmission. One of the characteristics of influenza viruses is their changing antigenicity. Minor changes in surface glycoproteins resulting from stepwise point mutations in HA/NA glycoproteins are called ''antigenic drift.'' Sequential amino acid changes occurring over a period of years resulting in HA/NA glycoprotein changes occur every 2 to 3 years and are termed ''antigenic shift.'' Influenza epidemics occur every 6 to 10 years and are due to antigenic shifts exposing the population to strains to which it has not been exposed previously. For this reason, pandemic influenza A has a high attack rate in individuals of all age groups who are not susceptible, particularly children. Unlike epidemics of influenza that occur during the winter months, pandemic influenza may occur at any time and spread rapidly from country to country, facilitated by travel. The twentieth century has experienced 3 influenza pandemics, 2 of which have emerged from China. The highest late excess fatalities occur are among the elderly, who succumb to influenza because of comorbid conditions/bacterial complications, whereas early deaths among young healthy patients are most often due to severe influenza pneumonia alone. 5, [22] [23] [24] [25] [26] Influenza has also been responsible for nosocomial outbreaks. Nosocomial influenza is usually due to influenza A and, less commonly, influenza B strains. In contrast to community-acquired infections, nosocomial outbreaks are brief, lasting 1 to 3 weeks versus months in community-acquired outbreaks. Health care workers may be important in initiating or spreading influenza in nursing homes, chronic care facilities, or hospitals. Nosocomial influenza has occurred in immunized hosts, suggesting that there is suboptimal protection in elderly nursing home residents. [23] [24] [25] [26] Swine influenza (H1N1) is spread primarily via aerosols/droplets and to a lesser extent via hand-to-face transmission. Avian (H5N1) and swine influenza (H1N1) may be transmitted in aircraft (unrecirculated cabin air) via aerosol/droplet transmission. Because swine influenza (H1N1), like avian influenza (H5N1), is often accompanied by gastrointestinal symptoms (ie, diarrhea), there may be potential for viral spread from feces. As with seasonal human influenza A, swine influenza (H1N1) may be spread nosocomially. 27 

Mild to moderate influenza is clinically indistinguishable from illnesses caused by other respiratory viruses that present as influenzalike illnesses (ILIs). Peak incidence of influenza historically is in February in the northern hemisphere, but the influenza season may start earlier and last into early spring. Avian influenza (H5N1) has a nonseasonal distribution, and swine influenza (H1N1) has occurred in summer and winter. Excluding pandemics and epidemics, influenza is a relatively mild 3-day illness, that is, a mild respiratory infection with a high attack rate and low mortality. Pandemic influenza also has a high attack rate, but due to highly virulent strains has a high mortality. [22] [23] [24] [25] 28 In adults, severe influenza A has a distinctive clinical presentation, which is not easily confused with other causes of viral pneumonia. 23, 29, 30 Like severe acute respiratory syndrome (SARS), hantavirus pulmonary syndrome (HPS), and adenovirus, severe influenza A pneumonia begins abruptly, but influenza A patients often can recall the exact time of onset of the illness. Severe human seasonal influenza A is accompanied by fever higher than 39 C/102 F and chills, accompanied by severe myalgias and dry cough with or without hemoptysis. Purulent sputum suggests superimposed bacterial community-acquired pneumonia (CAP) due to MSSA/CA-MRSA. Another noteworthy feature of human seasonal influenza is severe debilitating fatigue rapidly making victims bedridden. Prostration is profound and is accompanied by headache and prominent myalgias. Some infections present with myalgias, but the myalgias of influenza are peculiarly severe and are localized to the neck and back. Retro-orbital pain is common, and conjunctival suffusion may be present in severe seasonal human influenza A. Conjunctival suffusion may be present in avian influenza (H5N1) but is uncommon with swine influenza (H1N1). The clinical constellation of an ILI with fever higher than 39 C/102 F and severe myalgias especially of the neck/ back, with profound prostration, clinically differentiates severe influenza A in adults from ILIs ( Table 1) . [22] [23] [24] [25] 28, 30 The clinical presentation of avian influenza (H5N1) resembles severe human influenza A in adults and affects primarily young healthy adults, whereas nonepidemic pandemic/epidemic human influenza A primarily affects the very young, elderly, and debilitated. Pandemic influenza A affects primarily young healthy adults (ie, ''pandemic signature'') rather than the very young, elderly, and immunocompromised. Swine influenza (H1N1) has demonstrated its ''pandemic signature,'' that is, most fatal cases have occurred in young healthy adults. 28, 31 Several nonspecific laboratory test abnormalities are associated with human influenza A in adults. The severity of human influenza A is related to the degree/duration of leukopenia and relative lymphopenia. 31, 32 The nonspecific laboratory test hallmark of influenza A (human, avian, and swine) is otherwise unexplained relative lymphopenia. Relative lymphopenia is an inconsistent feature of swine influenza (H1N1) in children; lymphocytosis is more common. In adults, relative lymphopenia is usually accompanied by thrombocytopenia. In adults with human and avian (H5N1) influenza, leukopenia if present may be an indicator of severity. Leukopenia in swine influenza (H1N1) when present usually occurs with relative lymphopenia and thrombocytopenia. 33 Atypical lymphocytes are not a usual feature of swine influenza (H1N1) in adults but may be present in children.

From a radiographic perspective, influenza (human, avian, swine) has no distinctive features. Initially, the chest radiograph (CXR) shows no or minimal infiltrates. Later, (>48 hours) bilateral patchy interstitial infiltrates appear as influenza pneumonia progresses. The presence of focal segmental/lobar infiltrates on the admission CXR of adults with influenza indicates simultaneous bacterial CAP, due to Staphylococcus aureus (MSSA/CA-MRSA) CAP. 30 Patients with influenza/ILI and simultaneous S aureus CAP present with purulent sputum, high spiking fevers, often with cyanosis/hypotension. S aureus CAP, whether due to methicillin-sensitive S aureus (MSSA) or methicillin-resistant S aureus (MRSA), presents in the same way clinically and on CXR. The CXR of S aureus (MSSA/MRSA) CAP in patients with influenza pneumonia are characterized by rapid cavitation in 72 hours or less. In adults, S aureus (MSSA/MRSA) CAP occurs only in patients with influenza/ILI ( Table 2) . 30, 31, [34] [35] [36] [37] [38] Gastrointestinal symptoms (ie, nausea, vomiting, or diarrhea) are more common with avian and swine influenza (H1N1) than with human influenza. Serum aspartate and alanine transaminases (AST/ALT) are often mildly/transiently elevated in avian (H5N1) and swine influenza (H1N1). Another key laboratory finding in swine influenza (H1N1) patients is an elevated creatine phosphokinase (CPK). Some patients with highly elevated CPKs may also have rhabdomyolysis. Seasonal human influenza A and avian influenza A (H5N1) may have mild to moderate elevations of the serum lactate dehydrogenase (LDH). Whereas certain nonspecific laboratory abnormalities are typical of swine influenza (H1N1), for example, otherwise unexplained relative Swine Influenza (H1N1) Pneumonia lymphopenia, thrombocytopenia, mildly elevated AST/ALT, and elevated CPKs, other findings argue against the diagnosis, for example, elevated serum ferritin levels, hypophosphatemia, elevated cold agglutinin titers, and so forth. [30] [31] [32] 34 In influenza (human, avian, swine) pneumonia, hypoxemia is a reflection of the severity of influenza in the interstitium of the lungs. Viral involvement of the lung interstitium may result in an oxygen diffusion defect manifested as hypoxemia and an increased A-a gradient. The greater the degree/duration of hypoxemia (A-a gradient >35), the more severe and potentially fatal is influenza (human, avian, swine) pneumonia. 30, 31 As with avian influenza (H5N1), hospitalized adults with swine influenza (H1N1) pneumonia rarely present with or subsequently develop bacterial pneumonia CAP. 33, 36 During the 1957 to 1958 Asian influenza A pandemic, some patients presented with influenza A pneumonia and simultaneous S aureus CAP. Still others, especially the elderly, later developed Streptococcus pneumoniae or Haemophilus influenzae CAP 1 to 2 weeks into their recovery. As with avian influenza (H5N1), young healthy adults with swine influenza (H1N1) pneumonia, have only rarely presented with superimposed S aureus (MSSA/CA-MRSA) CAP. Adult swine influenza (H1N1), like avian influenza (H5N1) pneumonia simultaneous or subsequent bacterial CAP remains relatively rare. [36] [37] [38] [39] [40] 

The differential diagnosis of severe viral CAPs in normal hosts includes cytomegalovirus (CMV), and adenovirus, and in compromised hosts RSV and CMV. Viral pneumonias presenting as severe CAPs have a similar radiological appearance, that is, no/ minimal infiltrates early (<48 hours), followed later (>48 hours) by bilateral diffuse patchy interstitial infiltrates. Adult influenza A pneumonia (human, avian, swine) as well as other severe viral CAPs are accompanied by variable degrees of hypoxemia and a high A-a gradient >35. Bacterial CAP rarely, if ever, complicates severe CMV or adenoviral CAP. 30 In general, viral pneumonias are not accompanied by pleuritic chest pain because pathophysiologically they are interstitial and not pleurally based but influenza A may be accompanied by bilateral ''pleuritic'' chest pain. The ''pleuritic chest pain'' of influenza A pneumonia is due to direct viral involvement of the intercostal muscles mimicking pleuritic chest pain. The pleuritic chest pain of bacterial CAPs is unilateral and related to the location of the underlying infiltrate. 30 Influenza/ILI complicated by simultaneous CA-MRSA/MSSA CAP is characterized by a necrotizing pneumonia with rapidly cavitating infiltrates on CXR with or without pleuritic chest pain. MSSA/ CA-MRSA (PVL1 strains) with influenza/ILI is often accompanied by cyanosis/hypotension (see Table 2 ). [36] [37] [38] [39] [40] Swine influenza (H1N1) resembles avian influenza (H5N1) in its predilection for young healthy adults. [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] The epidemiologic clue to avian influenza (H5N1) is recent close contact with infected poultry or people in Europe or Asia. The diagnosis of avian influenza (H5/N1) may be missed if the hemagglutinin inhibition (HI) test is used to diagnose influenza A because this test is insensitive to avian hemagglutinins. 30, 39 The diagnosis of avian influenza (H5N1) is by hemagglutinin-specific reverse transcription-polymerase chain reaction (RT-PCR) for avian influenza (H5N1).

The other illness that does not clinically resemble influenza A is SARS. Unlike adult human seasonal influenza A, loose stools/diarrhea occurs in some and the illness lasts longer than 3 days. In contrast to influenza/avian influenza, the white blood cell (WBC) count and platelet counts in SARS are usually normal but may be slightly decreased. Relative lymphopenia is present, as are mild increases in the serum transaminases (AST/ALT). Like seasonal human influenza A, elevations of the CPK and LDH are not uncommon. Diagnosis of SARS is by specific serology or viral isolation. 30, 51 The clinical clue to SARS is the recent contact history with infected poultry or someone with SARS from Europe or Asia. Unlike seasonal human influenza A, SARS is a biphasic infection. At onset, fever decreases after a few days and the patient improves, but unlike seasonal human influenza A, fever recurs in a few days when the patient re-presents with signs and symptoms of viral pneumonia ie, CXR shows bilateral patchy interstitial infiltrates. Like avian influenza (H5N1), SARS has not been complicated by bacterial CAP. 30, 50, 51 In the differential diagnosis of influenza/ILIs, HPS should be considered if there has been close contact usually after about 2 weeks postexposure to a rodent. 52 Like SARS, HPS is a biphasic illness, that is, the initial phase is the febrile phase, followed by the cardiopulmonary phase. Later, HPS patients progress through an oliguric/ diuretic phase and finally to a convalescent phase. The distinguishing clinical feature of HPS is noncardiogenic pulmonary edema. HPS is not a 3-day illness like influenza. In HPS leukocytosis (up to 90,000/mm 3 ) rather than leukopenia is the rule. The nonspecific laboratory hallmark of HPS is the presence of immunoblasts. 30, 52 Diagnosis of HPS is by IgM enzyme-linked immunosorbent assay or RT-PCR ( Table 3) .

Sporadic seasonal human influenza A cases may occur throughout the year, but influenza activity in the northern hemisphere peaks in February (November-March), and in the southern hemisphere in July (May-September). Influenza occurring during the peak influenza season is often more severe than that which occurs sporadically throughout the year. [22] [23] [24] [25] In adults with swine influenza (H1N1), pneumonia presents in adults as an ILI with a temperature higher than 39 C (102 F) accompanied by prominent myalgias; these are the key clinical findings. Many patients also have headache, sore throat, or dry cough, with or without loose stools/diarrhea. Conjunctival suffusion is rare. The onset of swine influenza (H1N1) pneumonia is often abrupt but a preceeding ILI prodrome is common. Mild cases of swine influenza (H1N1) are indistinguishable from ILIs. Adult patients who require hospitalization have characteristic clinical nonspecific laboratory abnormalities. [17] [18] [19] [20] In adults hospitalized with swine influenza (H1N1) pneumonia, otherwise unexplained relative lymphopenia is uniformly present. 34 However, clinicians must be careful to not ascribe relative lymphopenia in patients to swine influenza (H1N1) pneumonia until the patient's medical history is reviewed for other disorders associated with relative lymphopenia. Besides human seasonal and avian influenza other infectious causes of relative lymphopenia include CMV, human herpesvirus (HHV)-6, HHV-8, human immunodeficiency virus (HIV), miliary tuberculosis (TB), Legionnaire's disease, typhoid fever, Q fever, brucellosis, SARS, malaria, babesiosis, Rocky Mountain spotted fever (RMSF), histoplasmosis, dengue fever, Chickungunya fever, ehrlichiosis, parvovirus B19, HPS, West Nile encephalitis (WNE), and viral hepatitis (early). Noninfectious causes of relative lymphopenia include cytotoxic drugs, steroids, sarcoidosis, systemic lupus erythematosus (SLE), lymphoma, rheumatoid arthritis (RA), radiation therapy, Wiskott-Aldrich syndrome, Whipple's disease, severe combined immunodeficiency disease (SCID), common variable immune deficiency (CVID), Di George's syndrome, Nezelof's syndrome, intestinal lymphangiectasia, constrictive pericarditis, tricuspid regurgitation, Kawasaki's disease, idiopathic CD 4 cytopenia, Wegener's granulomatosis, acute/chronic renal failure, hemodialysis; myasthenia gravis, celiac disease, alcoholic cirrhosis, coronary bypass, congestive heart failure (CHF), acute pancreatitis, and carcinomas. 30 Relative lymphopenia with swine influenza (H1N1) pneumonia may be profound and prolonged. The degree/duration of relative lymphopenia also has prognostic implications. Typically, an increase in the percentage of lymphocytes precedes clinical Swine Influenza (H1N1) Pneumonia improvement. 30 Atypical lymphocytes are present in a variety of viral illnesses but are not usually present in adults with influenza A or avian influenza (H5N1). Also, atypical lymphocytes are not a feature of adult swine influenza (H1N1) but may be present in children with swine influenza (H1N1). 30 With swine influenza (H1N1) pneumonia, thrombocytopenia does not occur as an isolated entity but accompanies/follows relative lymphopenia. Leukocytosis, rather than leukopenia, is the rule in hospitalized adults with swine influenza (H1N1) pneumonia. When leukopenia is present, it occurs together with the relative lymphopenia or thrombocytopenia. Also, as with severe seasonal human influenza A, leukopenia may rarely be an isolated finding in fatal cases of swine influenza (H1N1) pneumonia in adults (Figs. 1-4) . 30, 53 Another important nonspecific laboratory clue in adult influenza (human, swine, and avian) are elevated CPKs. Severe swine influenza (H1N1) pneumonia, like seasonal human influenza A and avian influenza (H5N1) pneumonia, may be accompanied by high elevations of CPK, with or without rhabdomyolysis. Highly elevated cold agglutinin titers are not a feature of swine influenza (H1N1) pneumonia in adults, and their presence should suggest another diagnosis, for example, Mycoplasma pneumoniae CAP. In adults with swine influenza (H1N1) pneumonia, serum transaminases (AST/ ALT) are often transiently mildly/moderately elevated. Highly elevated serum ferritin levels or hypophosphatemia are not features of swine influenza (H1N1) pneumonia and should suggest an alternate diagnosis, for example, Legionnaire's disease. In adults, a quick way to differentiate ILIs from swine influenza (H1N1) pneumonia is a fever higher than 39 C/102 F accompanied by severe myalgias with otherwise unexplained relative lymphopenia thrombocytopenia, elevated serum transaminases (AST/ ALT) or an elevated CPK. 30, 53 A diagnostic weighted point score system was developed at Winthrop-University Hospital by the Infectious Disease Division during the ''herald wave'' of swine influenza (H1N1) pandemic to clinically differentiate admitted adults with swine influenza (H1N1) pneumonia from ILIs and other patients with cardiac/pulmonary symptoms. While the diagnostic point score system was accurate and useful early in the pandemic, a more simplified/rapid approach was developed; the swine influenza diagnostic triad. The Winthrop-University Hospital Infectious Disease Division's diagnostic triad was then used as the basis for making a probable clinical diagnosis of swine influenza (H1N1) in rapid influenza diagnostic tests (RIDT)-negative hospitalized adults, to determine which patients should be on influenza precautions and treated with oseltamivir ( Table 4 , Box 1). 54 Also, a key component in the Winthrop-University Hospital Infectious Disease Division's diagnostic swine influenza triad for the diagnosis of hospitalized adults with swine influenza (H1N1) pneumonia was dry cough, fever, and a CXR without focal segmental/lobar infiltrates. 30, 53 Adult patients presenting with an ILI, fever, and shortness of breath with an admission CXR with focal segmental/lobar infiltrates invariably had an alternate diagnosis, namely, CHF, asthma, acute exacerbation of chronic bronchitis (AECB), preexisting lung disease, or bacterial CAP. In an adult hospitalized with an ILI without the diagnostic swine influenza triad, focal segmental/lobar infiltrate on the admission CXR effectively rules out the diagnosis of swine influenza (H1N1) pneumonia. 33 As the result of the experience in the 1957 to 1958 Asian influenza pandemic, there has been concern about the potential for simultaneous or sequential bacterial CAPs with pandemic influenza A. Patients presenting with human influenza A and CXR infiltrates that rapidly cavitate (within <72 hours) should suggest MSSA/CA-MRSA CAP superimposed underlying influenza/ILI. This presentation has been reported in the literature sporadically with seasonal human influenza A during the past few years. [55] [56] [57] [58] In adults, seasonal human influenza A pneumonia may also be complicated by subsequent bacterial CAP after a period of improvement (usually 5-7 days). Adults with human seasonal influenza A improve, then may re-present with new onset of fever and new focal segmental/lobar infiltrates on CXR. The pathogen in this setting is either S pneumoniae or H influenzae, not S aureus (MSSA/CA-MRSA). Adults with influenza A pneumonia presenting simultaneous MSSA/CA-MRSA CAP are critically ill, with high spiking fevers, cyanosis, and hypotension and a fatal outcome is not uncommon. However, most admitted adult patients with severe influenza A pneumonia have not been complicated by simultaneous or subsequent bacterial CAP.

In the recent avian influenza (H5N1) pneumonia experience in Europe and Asia, this has also been the case, that is, severe or fatal cases have not been complicated by simultaneous or subsequent bacterial CAP. [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] Deaths from severe avian influenza (H5N1) pneumonia have been due to severe hypoxemia, which is also the case with most fatal cases of seasonal human influenza A. In the ''herald wave'' of recent pandemic, the majority of swine influenza (H1N1) pneumonia deaths occurred primarily in young healthy adults without comorbidities. 56 The cause of death in most fatal swine influenza (H1N1) pneumonia cases has been due to severe hypoxemia and not due to simultaneous/subsequent bacterial CAP. [35] [36] [37] [38] [39] [40] The admission CXR is of critical importance in evaluating swine influenza (H1N1) pneumonia. Because CAP coinfections are rare, the presence of a focal segmental/ lobar infiltrates should suggest another diagnosis, for example, bacterial CAP. In hospitalized adults with swine influenza (H1N1) pneumonia, the admission CXR typically is clear without infiltrates or shows an accentuation of basilar markings/atelectasis which may be unilateral or bilateral. On CXR in severe cases, within 48 hours there is rapid progression to bilateral patchy interstitial infiltrates. Unilateral or bilateral small pleural effusions are not uncommon. Adult hospitalized patients with swine influenza (H1N1) pneumonia who present with, or rapidly develop bilateral patchy interstitial infiltrates, may also have small pleural effusions. Consolidation is unusual and if present it occurs, later in patients on ventilatory support. Cavitation is not a feature of swine influenza (H1N1) pneumonia in adults. 33 The Winthrop-University Hospital Infectious Disease Division's diagnostic swine influenza triad has been useful for the rapid clinical presumptive diagnosis of swine influenza (H1N1) pneumonia in hospitalized adults with negative RIDTs and a negative CXR, that is, accentuated basilar markings/atelectasis, but not focal segmental/lobar infiltrates, and differentiates swine influenza (H1N1) pneumonia from ILIs as well as bacterial pneumonias. 33, 54 

During ''herald wave'' of the swine influenza (H1N1) pandemic, an unexplained increase in Legionnaire's disease occurred before the usual late summer/early fall peak incidence of legionella CAP. This may be analogous to the increased incidence/severity of acute bacterial appendicitis during human influenza A/B outbreaks. Regardless of the mechanism, clinicians should be alert for Legionnaire's disease mimicing swine influenza (H1N1) pneumonia.

In adults the best non-specific laboratory test markers helpful in differentiating Legionnaire's disease from swine influenza (H1N1) pneumonia are the presence of focal segmental/lobar infiltrates on CXR, relative bradycardia, hypophosphatemia, and highly elevated ferritin levels. Serum procalcitonin levels (PCT) are not elevated in swine influenza (H1N1) pneumonia, but are elevated in Legionnaire's disease. The other atypical CAP that may be mimic Legionnaire's disease or swine influenza

ILI with dry cough, temperature higher than 39 C/102 F and a CXR with no focal/segmental lobar infiltrates plus one or more of these positive tests:

Respiratory fluorescent antibody (FA) viral panel

Probable swine influenza (H1N1) pneumonia (clinical criteria) ILI with temperature higher than 39 C/102 F with severe myalgias and a CXR with no focal/ segmental lobar infiltrates with negative influenza tests (see above) a plus this diagnostic triad: (H1N1) pneumonia is Q fever. Q fever CAP has many of the features of Legionnaire's disease, namely, elevated serum ferritin levels, mildly increased serum transaminases (AST/ALT), and relative bradycardia. However, Q fever CAP is often accompanied by splenomegaly, which is not a feature of Legionnaire's disease or swine influenza (H1N1) pneumonia. As with M pneumoniae, elevated cold agglutinins may occur with Q fever CAP but are not a feature of Legionnaire's disease or swine influenza (H1N1) pneumonia. Relative lymphopenia is common with Legionnaire's disease, Q fever, and swine influenza (H1N1) pneumonia, but leukopenia and thrombocytopenia are not laboratory markers of either Legionnaire's disease or Q fever CAP. 30, 33, 55 

Influenza virus is present in respiratory secretions early in the illness. Nasopharyngeal swabs or washings may be used for viral isolation. In general, higher concentrations of virus are found in nasal secretions than in oropharyngeal secretions. During influenza A epidemics, oropharyngeal secretions contain higher concentrations of influenza virions than nasal secretions. In alveolar macrophages, influenza A viruses produce cytopathogenic effects (CPEs), but are nonspecific and difficult to detect. CPEs due to influenza A are apparent in approximately 50% of cultures within 3 days of inoculation and in approximately 90% within 5 days. Identification of cells showing CPE may be verified using immunofluorescent technique or type/subtype specific antisera. The most common rapid method of influenza laboratory diagnosis is by FA techniques. For FA testing for respiratory viruses, nasopharyngeal aspirates are preferred to swabs. FA influenza assays identify viral antigens in infected respiratory epithelial cells. [22] [23] [24] [25] During the ''herald wave'' of the swine influenza (H1N1) pandemic in New York, it was realized that there were problems with screening tests, that is, RIDTs. It was hoped that rapid screening tests for influenza A would detect swine influenza (H1N1), an influenza A virus. Rapid influenza A test positivity was usually predictive of RT-PCR positivity for swine influenza (H1N1). It was quickly realized that negative rapid influenza A testing did not rule out swine influenza (H1N1). False negative rapid influenza A testing for swine influenza (H1N1) was 30%. Respiratory FA viral testing detects influenza A, influenza B, metapneumoviruses, RSVs, parainfluenza viruses, and adenoviruses. Unfortunately, respiratory FA viral testing did not correlate with either rapid influenza A testing or RT-PCR testing. Although the definitive test for swine influenza (H1N1) diagnosis remains RT-PCR, during the pandemic, RT-PCR testing was restricted. Restricted RT-PCR testing resulted in tremendous difficulties in making/ruling out the diagnosis of swine influenza (H1N1) and in initiating/discontinuing influenza precautions. [53] [54] [55] 59 Because of restricted swine influenza (H1N1) RT-PCR testing, clinical criteria were developed for patients presenting with ILIs who had a negative rapid influenza A test. By combining key clinical and nonspecific laboratory features, a clinical diagnosis of probable swine influenza was developed at Winthrop-University Hospital by the Infectious Disease Division. This permitted an operational clinical approach to placing admitted adult patients on influenza precautions/treatment, and was also useful in differentiating swine influenza (H1N1) from its mimics. 54 (see Box 1, Figs. 1-4 , Tables 3-5) .

Until relatively recently, there were no effective anti-influenza antivirals. Amantadine and rimantadine has been used for influenza prophylaxis/therapy and act by interfering with the attachment of the virus to uninfected hosts' respiratory epithelial cells. The current anti-influenza antivirals currently available are zanamivir and oseltamivir.

Both of these antivirals decrease the duration/severity of illness. Oseltamivir is administered orally but zanamivir is administered via an inhaler, which is problematic for some patients. 30 Unfortunately, there is now widespread resistance to oseltamivir, greatly diminishing the therapeutic options in influenza and avian influenza (H5N1). At present, oseltamivir remains effective against most strains of swine influenza (H1N1). Oseltamivir is usually given for 5 days, but in severe cases, therapy has been given for 10 days. For severely ill hospitalized patients with swine influenza (H1N1) pneumonia unable to take oral medications, eg, oseltamivir, peramivir is available from the CDC for IV administration. In severe cases of influenza A, amantadine may have some role because of its effect on dilatation of the distal bronchioles. By increasing distal bronchiolar aeration, oxygenation may be improved, which may be critical in severe influenza A. [60] [61] [62] [63] [64] [65] [66] [67] 

The prognosis of influenza A is related primarily to strain virulence. Most patients with mild to moderate influenza A recover without specific anti-influenza therapy. However, influenza A may be severe, and may be fatal in the very young and the elderly with impaired cardiopulmonary function. With pandemic influenza A, the prognosis depends on the virulence of the strain and may be fatal in young, healthy adults. Such has clearly been the case in the recent avian influenza (H5N1) epidemic in Asia whose fatalities, as in the 1918 to 1919 pandemic, were due in the main to influenza pneumonia and was frequently fatal without bacterial superinfection. Severe influenza A pneumonia with superimposed S aureus CAP have the worst prognosis. Others who initially present with influenza may later be complicated by subsequent bacterial pneumonia due to S pneumoniae or H influenzae, and have the same prognosis as noninfluenza patients with S pneumoniae or H influenzae CAP.

There is a late excess mortality with influenza A, that occurs after the acute episode eg, elderly patients with borderline cardiopulmonary function succumb to heart failure or acute myocardial infarction from the hypoxemia/stress of swine influenza (H1N1) pneumonia. In severe cases of respiratory failure/ARDS, extracorporeal membrane oxygenation (ECMO) has been lifesaving in some. 68 Although influenza is a 3-day illness, postinfluenza fatigue may last for weeks or months. In influenza, prognosis is worse in those patients who develop encephalitis. Following the 1918 to 1919 influenza pandemic, some patients developed Parkinson disease decades later. The prognosis in influenza depends on several factors including the virulence of the strain, the age/immune status of the host, cardiopulmonary function, and complications, for example, encephalitis or bacterial CAP. 1, 2, 16 The most important intervention in adults with severe swine influenza (H1N1) pneumonia is prolonged ventilatory support. Because these patients are not complicated by simultaneous or subsequent bacterial CAP, empiric antimicrobial therapy seems to be unnecessary in swine influenza (H1N1) pneumonia. The degree and duration of relative lymphopenia/leukopenia as well as the severity and duration of hypoxemia are key prognostic indicators. An improvement in relative lymphopenia and a decrease in oxygen (FIO 2 ) are predictive of recovery.

There are differences of opinion on the cause of early deaths in influenza pandemics. Most early deaths in young healthy individuals in the 1918-1919 pandemic seemed to be caused by influenza A pneumonia alone. Based on autopsy specimen cultures, which are notoriously unreliable, some believe the high mortality rate of the Swine Influenza (H1N1) Pneumonia 1918-1919 influenza pandemic was due to superimposed bacterial pneumonia, for example, S pneumoniae. Most lung specimens from autopsies of young healthy military recruits clearly show the pathologic changes of influenza alone. Based on the pathologic comparisons of viral and bacterial pneumonia, it seems that the majority of early deaths in young healthy military recruits was due to severe hypoxemia. Late excess mortality seems to have been due to influenza precipitated decompensation in those with antecedent borderline cardiopulmonary function/reserve. Most recently, S aureus was recognized as an important pathogen in the 1957-1958 Asian influenza A pandemic. In 1957-1958 Asian influenza A pandemic, influenza presented as pneumonia alone or simultaneously with S aureus or subsequently with S pneumoniae or H influenzae CAP. Because the 1957-1958 influenza A pandemic clinicians had modern bacteriologic and virologic diagnostic methods, clinicians attributed the excess mortality to late bacterial CAP. The unusual severity of the 1918-1919 influenza A pandemic seems to have been related to a particularly virulent strain of influenza A (H1N1), not unlike the virulence of avian influenza (H5N1). In the recent experience with avian influenza (H5N1), it is interesting to note that despite high mortality of w 60% in young adults, avian influenza deaths have been due to avian influenza (H5N1) pneumonia alone and not simultaneous/subsequent bacterial CAP. [69] [70] A summary of lessons learned during the ''herald wave'' of the swine influenza (H1N1) pandemic is presented here in tabular form (Tables 6 and 7) . The important take-home lessons for clinicians in the summary relate to laboratory and clinical diagnosis, infection control concerns, and empiric antibiotic use. [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] 

Evolution of infectious disease

The Cambridge world history of human disease

The Cambridge encyclopedia of human paleopathology

Classic descriptions of disease

The influenza viruses and influenza

Influenza: historical aspects of epidemics and pandemics

Before our time: 1918 influenza, encephalitis lethargica, parkinsonism

The symptomatology and complications of influenza

The Spanish flu in Denmark

Influenza in the preantibiotic era

The pathology of influenza

Comments on the pathology and bacteriology of fatal influenza cases as observed at Camp Devens, Mass

The pathophysiology of influenzal pneumonia in 1918

Wolters-Noordhoff

Studies on epidemic influenza, comprising clinical and laboratory investigations by members of the faculty of the school of medicine

London: His Majesty's Stationery Office

Outbreak of swine-origin influenza A (H1N1) virus infection-Mexico

Swine-origin influenza A (H1N1) virus infections in a school

Towards a sane and rational approach to management of Influenza H1N1 2009

Swine-origin influenza virus A (H1N1)v: lessons learnt from the early phase of the epidemic

Infectious disease. As swine flu circles globe, scientists grapple with basic questions

The influenza viruses and influenza

Clinical virology: the evaluation and management of human viral infections. Philadelphia: WB Saunders

Textbook of influenza

Textbook of human virology

Influenza viruses

Influenza virus

Seasonal, avain and novel H1N1 influenza: prevention and treatment modalities

Seasonal influenza in adults and children: diagnosis, treatment, chemoprophylaxis and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America

Pneumonia essentials

The clinical diagnosis of severe viral influenza A

Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs

Imaging findings in a fatal case of pandemic swine-origin influenza A (H1N1)

Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection

A useful clinical approach to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections

Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy

Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and management

Staphylococcus aureus communityacquired pneumonia during the 2006 to 2007 influenza season

Fatal co-infection with swine origin influenza virus A/H1N1 and community-acquired methicillin-resistant Staphylococcus aureus

Bacterial pneumonia rare with fatal swine influenza (H1N1) pneumonia: if chest films have no focal segmental/lobar infiltrates, empiric antibiotic therapy is unnecessary

Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam

Writing Committee of the Second World Health Organization consultation on clinical aspects of human infection with avian influenza A (H5N1) virus. Update on avian influenza A (H5N1) virus infection in humans

Avian influenza: a review

Influenza-associated pneumonia in a Turkish area with endemic avian influenza

Clinical review: update of avian influenza A infections in humans

Pathology of fatal human infection associated with avian influenza A H5N1 virus

Avian influenza A (H5N1) in 10 patients in Vietnam

Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues

Human infection with highly pathogenic H5N1 influenza virus

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus

Severe acute respiratory syndrome: clinical features, diagnosis, and management

Hantavirus pulmonary associated with Monongahela virus

Swine influenza H1N1: diagnostic dilemma early in the pandemic

Winthrop-University Hospital infectious disease division's swine influenza (H1N1) pneumonia diagnostic weighted point score system for adults with Influenza Like Illnesses (ILIs) and negative Rapid Influenza Diagnostic Tests (RIDTs)

The diagnostic importance of relative lymphopenia as a marker of swine influenza (H1N1) in adults

Studies on influenza in the pandemic of 1957-1958. Pulmonary complications of influenza

Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A

Pulmonary infections complicating Asian influenza

Rapid antigen tests for diagnosis of pandemic (Swine) influenzae A/H1N1

Amantadine may be lifesaving in severe influenza A

Update: drug susceptibility of swine-origin influenza A (H1N1) viruses

Oseltamivir resistance in human seasonal influenza viruses (A/H1N1) in EU and EFTA countries: an update

A change in the effectiveness of amantadine for the treatment of influenza over the

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

Fatal oseltamivir-resistant influenza virus infection

Swine flu outbreak. What role for antiviral drugs?

Susceptibility of highly pathogenic A (H5N1)Avian influenza viruses to the neuraminidase inhibitors and adamantanes

Extracorporeal Membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome

Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies

Influenza pandemic: lessons from the past raise questions for the future

Swine influenza (H1N1): contact investigation burden because of failure to institute influenza precautions with negative rapid influenza A diagnostic test results

Nosocomial swine influenza (H1N1) pneumonia: lessons learned from an illustrative case

Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy

Critically ill patients with 2009 influenza A (H1N1) in Mexico

Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States

Hospitalized patients with novel influenza A (H1N1) infection-California

Critically ill patients with 2009 influenza A (H1N1) in Canada

Intensive-care patients with severe novel influenza A (H1N1) virus infection-Michigan

Clinical & epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China

Swine influenza (H1N1) pneumonia: bacterial airway colonization common but fatalities due to bacterial pneumonia remain relatively rare

Swine flu and antibiotics

Lung pathology in fatal novel human influenza A (H1N1) infection

Legionnaire's disease mimicking swine influenza (H1N1) pneumonia

Case report: a fatal case of severe H1N1 influenza A (Swine flu) pneumonia in an HIV positive patient

Rapid clinical diagnosis in fatal swine influenza (H1N1) pneumonia in adult with negative rapid influenza diagnostic tests (RIDTs): diagnostic swine influenza triad